Investment
Features
FeesSafety
Academy
More
Pluang+

Big Ridge Gold to showcase Hope Brook project at European mining investor forum and roadshow in October

Market News
18 Sep 2026
Newsfile Corp
View Source
Bullish
Big Ridge Gold to showcase Hope Brook project at European mining investor forum and roadshow in October

Big Ridge Gold Corp. will participate in the inaugural Gentile Mining Investor Forum in London on October 19 and a subsequent European roadshow in Paris, Frankfurt, Zurich, and Munich from October 20-23. This event, organized by investor Michael Gentile and Amvest Capital, aims to connect mining companies with global investors. Big Ridge will present its 100% owned Hope Brook Gold Project, currently undergoing environmental and economic assessments, to attract new investment. The forum and roadshow provide a platform for Big Ridge to expand its investor base across Europe and highlight its advanced-stage mining projects.

Big Ridge Gold Corp.'s participation in the Gentile Mining Investor Forum and European roadshow is notable. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 18, 2026 17:42 WIB: of 33 priced US stocks, 24 rose and 9 fell. Agnico Eagle Mines Ltd (AEM) rose 1.44% to USD 204.27 with 100% buy orders, Sibanye Stillwater Ltd (SBSW) rose 1.37% to USD 11.71 with 100% buy orders, and Barrick Gold Corp (B) rose 1.29% to USD 44.25 despite 87% sell orders.

More News

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
1 hour ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
1 hour ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
2 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim has raised its price target for Restaurant Brands International (QSR) to $86 from $85 and reiterated a Buy rating, reflecting confidence in the company's strategic growth. Restaurant Brands International is enhancing shareholder value thro...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App